Success Metrics

Clinical Success Rate
87.5%

Based on 14 completed trials

Completion Rate
88%(14/16)
Active Trials
2(10%)
Results Posted
7%(1 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_2
2
10%
Ph phase_4
6
29%
Ph not_applicable
4
19%
Ph phase_1
2
10%
Ph phase_3
3
14%

Phase Distribution

2

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
2(11.8%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
6(35.3%)
N/ANon-phased studies
4(23.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

14 of 16 finished

Non-Completion Rate

12.5%

2 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(14)
Terminated(2)
Other(3)

Detailed Status

Completed14
unknown3
Terminated2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.8%)
Phase 22 (11.8%)
Phase 33 (17.6%)
Phase 46 (35.3%)
N/A4 (23.5%)

Trials by Status

completed1467%
terminated210%
unknown314%
recruiting210%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05546320Phase 2

Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

Completed
NCT05257824Phase 4

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Completed
NCT06591299Phase 3

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

Recruiting
NCT04057300Phase 4

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

Completed
NCT04237935

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Completed
NCT04237922

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Completed
NCT05960721Not Applicable

Low-dose NOAC Versus GDMT After LAAO

Recruiting
NCT04333407Not Applicable

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Terminated
NCT03649711Phase 3

Chronic Kidney Disease (CKD) Platelet Study

Completed
NCT03661411Phase 4

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

Completed
NCT04001894Phase 4

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Completed
NCT04229264Phase 3

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Unknown
NCT04431349

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Completed
NCT04171687Phase 1

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Completed
NCT03599284Phase 2

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Completed
NCT03942458Phase 1

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

Completed
NCT04060914Phase 4

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Unknown
NCT03224923Phase 4

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Terminated
NCT03759067Not Applicable

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients

Completed
NCT03691688

The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA)

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21